Carrboro, North Carolina
United States
24
2024-12-19
The entities that hold a legal rights for patent applications filed by inventor Barta Thomas E.:
Thomas E. Barta from Carrboro, US has applied for patents for these inventions. The list has both pending applications and granted patents:
COMPOSITION AND METHODS OF USE OF NOVEL PHENYLALANINE SMALL ORGANIC COMPOUNDS TO DIRECTLY MODULATE PCSK9 PROTEIN ACTIVITY
#2 | 2024-04-18METHOD TO TREAT LIPID DYSREGULATION BY MODULATING ACTIVITY OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) PROTEIN WITH SMALL MOLECULE LIGANDS
#3 | 2022-08-25COMPOUNDS FOR THE MODULATION OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9)
#4 | 2022-06-23Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)
#5 | 2022-02-17Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use
#6 | 2021-10-07Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity
#7 | 2021-09-09Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands
#8 | 2021-08-05Phenylalanine small organic compounds to directly modulate PCSK9 protein activity
#9 | 2021-02-04Compounds for binding proprotein convertase subtilisin/kexin type 9
#10 | 2020-08-13Method to treat lipid dysregulation by modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein activity with small molecule ligands
#11 | 2020-08-13Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use
#12 | 2020-07-02Composition and methods of use of tetrahydroisoquinoline small molecules to bind and modulate PCSK9 protein activity
#13 | 2019-11-28Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity
#14 | 2018-10-25Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity
#15 | 2018-09-06Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use
#16 | 2018-08-23Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity
#17 | 2017-08-31Composition and methods of use of small molecules as binding ligands for the modulation of proprotein convertase subtilisin/kexin type 9(PCSK9) protein activity
#18 | 2016-03-24Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels
#19 | 2008-10-30Tetrahydroindole and Tetrahydroindazole Derivatives
#20 | 2008-02-072, 8-disubstituted Naphthyridine Derivatives
#21 | 2007-09-06Cyclohexylamino Benzene, Pyridine, and Pyridazine Derivatives
#22 | 2007-08-09Carbazole derivatives
#23 | 2006-02-16Methotrexate derivatives useful for treating cancer and arthritis
#24 | 2006-02-092,8-disubstituted naphthyridine derivatives
1481149 ⎘